Cargando…

Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management

The advent of immunotherapy, specifically of immune checkpoint inhibitors (ICIs), for the treatment of solid tumors has deeply transformed therapeutic algorithms in medical oncology. Approximately one-third of patients treated with ICIs may de velop immune-related adverse events, and the gastrointes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terrin, Maria, Migliorisi, Giulia, Dal Buono, Arianna, Gabbiadini, Roberto, Mastrorocco, Elisabetta, Quadarella, Alessandro, Repici, Alessandro, Santoro, Armando, Armuzzi, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380448/ https://www.ncbi.nlm.nih.gov/pubmed/37511260 http://dx.doi.org/10.3390/ijms241411504

Ejemplares similares

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
por: Gabbiadini, Roberto, et al.
Publicado: (2023)

Ileal Pouch–Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and Therapy
por: Gabbiadini, Roberto, et al.
Publicado: (2022)

Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano
por: Bartocci, Bianca, et al.
Publicado: (2023)

Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in Therapy
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections
por: Cavalli, Carolina Aliai Micol, et al.
Publicado: (2023)

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications
por: Felice, Carla, et al.
Publicado: (2023)

Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?
por: Solitano, Virginia, et al.
Publicado: (2023)

Technological advances in inflammatory bowel disease endoscopy and histology
por: Alfarone, Ludovico, et al.
Publicado: (2022)

Endoscopic Surveillance in Inflammatory Bowel Diseases: Selecting a Suitable Technology
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts
por: Rizzo, Giulia, et al.
Publicado: (2023)

EUS-guided hepaticogastrostomy and antegrade direct peroral cholangioscopy: An effective alternative to overcome the distance (with video)
por: Fugazza, Alessandro, et al.
Publicado: (2021)

An Unexpected Anemia Hiding a Rare Syndrome With Overlapping Phenotypes
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy
por: Repici, Alessandro, et al.
Publicado: (2020)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

Single-session EUS-guided gastroenterostomy and hepaticogastrostomy using dedicated metal stents (with videos)
por: Anderloni, Andrea, et al.
Publicado: (2021)

Mucosal healing in ulcerative colitis: surveillance or colectomy?
por: Andrisani, Gianluca, et al.
Publicado: (2013)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Personeni, Nicola, et al.
Publicado: (2021)

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?
por: Furfaro, Federica, et al.
Publicado: (2021)

Teaching after the pandemic: The role of technostress and organizational support on intentions to adopt remote teaching technologies
por: Gabbiadini, Alessandro, et al.
Publicado: (2023)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
por: Pugliese, Daniela, et al.
Publicado: (2016)

Gut microbiome and checkpoint inhibitor colitis
por: Sehgal, Kanika, et al.
Publicado: (2021)

Checkpoint Inhibitor-Induced Colitis: An Update
por: Losurdo, Giuseppe, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
por: Khan, Jaffar, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management
por: Tang, Liansha, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Refractory Checkpoint Inhibitor Colitis Responsive to Ustekinumab
por: Perez Del Nogal, Genesis, et al.
Publicado: (2022)

Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab
por: Pugliese, Daniela, et al.
Publicado: (2022)

Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis
por: Fredrick, Thomas W, et al.
Publicado: (2022)

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
por: Daperno, Marco, et al.
Publicado: (2019)

Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question
por: Gabbiadini, Roberto, et al.
Publicado: (2022)

Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Immune Checkpoint Inhibitor-Induced Acute Pancreatitis and Colitis
por: Pagan, Andrea, et al.
Publicado: (2020)

Immune-mediated Colitis from Dual Checkpoint Inhibitors
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
por: Alorfi, Nasser M, et al.
Publicado: (2022)

Checkpoint Inhibitor Colitis With Superimposed Clostridioides difficile Infection
por: Mohammad, Al Wahadneh, et al.
Publicado: (2023)

Overlapping Hepatotoxicity and Colitis Associated with Immune Checkpoint Inhibitors
por: Malik, Alexander, et al.
Publicado: (2023)

Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
por: Profili, Nicia I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_51muamtvv7d3kokgkqjk1pkpd0